Watch Ticker

Rhythm Pharmaceuticals, Inc. Common Stock

Go to Rhythm Pharmaceuticals, Inc. Common Stock Website

$90.01

0.00 (0.00%)

Live

Previous Close

$90.01

Day Range

$0 - $0

Previous Day Range

$87.99 - $90.985

Market Cap

$5.8 billion USD

Day Vol.

Previous Day Vol.

639226

Currency

USD

Primary Exchange

Nasdaq

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, in...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Rhythm Pharmaceuticals, Inc. - Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update

Rhythm Pharmaceuticals reported strong Q1 2025 results, with $37.7 million in net product revenue from IMCIVREE and positive data from its pivotal Phase 3 trial of setmelanotide in acquired hypothalamic obesity. The company also provided updates on its pipeline and anticipated upcoming milestones.

Related tickers: RYTM.

Read Full Article

N/A - Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals announced positive topline results from its pivotal Phase 3 TRANSCEND trial evaluating setmelanotide for the treatment of acquired hypothalamic obesity. The trial met its primary endpoint with a statistically significant and clinically meaningful reduction in body mass index (BMI) with setmelanotide compared to placebo in both adult and pediatric patients.

Related tickers: RYTM.

Read Full Article

Trending Tickers

Please sign in to view